Latest Expert Opinions

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
August 13, 2018

It's fallen since the winter. Hang your hat around $13-15. That said, you can find a better financial name elsewhere. If this falls anouther dollar, it'll like fall to $9.

Show full opinionHide full opinion
ING Groep NV (ING-N)
August 13, 2018

It's fallen since the winter. Hang your hat around $13-15. That said, you can find a better financial name elsewhere. If this falls anouther dollar, it'll like fall to $9.

TOP PICK
TOP PICK
August 13, 2018

It's been beaten up, but the technicals look really good. It's broken a downtrend. Everything is lined up from a fundamental and technical perspective. If it breaks $8, then it should have no resistence to reach $10. Nice dividend above 6%. (Analysts' price target: $8.83)

Show full opinionHide full opinion
Extendicare Inc (EXE-T)
August 13, 2018

It's been beaten up, but the technicals look really good. It's broken a downtrend. Everything is lined up from a fundamental and technical perspective. If it breaks $8, then it should have no resistence to reach $10. Nice dividend above 6%. (Analysts' price target: $8.83)

TOP PICK
TOP PICK
August 13, 2018

An overlooked Canadian tech company. Fantastic blaance sheet. There's organic growth through acqusitions. They've been on the bad side of shorts. Can be volatile, but steady when the market is forthy. Has recommend it before. (Analysts' price target: $58.07)

Show full opinionHide full opinion
Open Text (OTEX-T)
August 13, 2018

An overlooked Canadian tech company. Fantastic blaance sheet. There's organic growth through acqusitions. They've been on the bad side of shorts. Can be volatile, but steady when the market is forthy. Has recommend it before. (Analysts' price target: $58.07)

TOP PICK
TOP PICK
August 13, 2018

Healthcare is in a secular bull market. Fantastsic trend upwards over the past year. Executing well. (Analysts' price target: $280.23)

Show full opinionHide full opinion

Healthcare is in a secular bull market. Fantastsic trend upwards over the past year. Executing well. (Analysts' price target: $280.23)

COMMENT
COMMENT
August 13, 2018

The $4 level is significant. It'll be a fight to rise to $4. Yes, their insider buying is a good sign, but expect volatility here. To average in, look at the $2.63 level.

Show full opinionHide full opinion

The $4 level is significant. It'll be a fight to rise to $4. Yes, their insider buying is a good sign, but expect volatility here. To average in, look at the $2.63 level.